VP3.15
VP3.15 is a potent, orally bioavailable and CNS-penetrant dual phosphodiesterase (PDE) 7- glycogen synthase kinase (GSK) 3 inhibitor, with IC50s of 1.59 μM and 0.88 μM for PDE7 and GSK-3, respectively. VP3.15 has neuroprotective and neuroreparative activities, thus as potential combined anti-inflammatory and pro-remyelinating therapies for multiple sclerosis (MS) [1].
Product Specifications
CAS Number
1281681-54-6
UNSPSC
12352005
Target
GSK-3; Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease; PI3K/Akt/mTOR; Stem Cell/Wnt
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/vp3-15.html
Solubility
10 mM in DMSO
Smiles
N1(CC/N=C2N=C(C3=CC=CC=C3)N(C4=CC=CC=C4)S/2)CCOCC1
Molecular Formula
C20H22N4OS
Molecular Weight
366.48
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PDE7
Citation 01
J Biol Chem. 2023 Aug;299 (8) :104991.|J Biol Chem. 2025 Jan 27:108244.|Pennsylvania State University. 2025.
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Phospho-TPH2 (Ser19) Rabbit Polyclonal Antibody (APC)
![Mouse Monoclonal alpha-Synuclein Antibody (2A7) [DyLight 550]](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
Mouse Monoclonal alpha-Synuclein Antibody (2A7) [DyLight 550]
